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nTATE-OF-THE-ART PAPER2315Vascular Healthedro R. Moreno, Javier Sanz, Valentin Fuster
his review by Moreno and colleagues focuses on the mechanisms and pathways whereby
rteries can be maintained or restored to a healthy state. Three systems for maintaining
ardiovascular homeostasis are explored—the regenerative production of endothelial
rogenitor cells, vessel wall angiogenesis, and macrophage-mediated reverse cholesterol
ransport. Endothelial progenitor cells can restore vessel wall function and reduce
therosclerosis. Angiogenesis is necessary for reducing ischemia in the arterial wall; however,
eovessels are susceptible to intraplaque hemorrhage. Finally, therapies that enhance the
everse cholesterol transport system should induce plaque regression through cholesterol efflux.CLINICAL RESEARCH LINICAL TRIALS2324Similar Results for SES or MIDCAB Surgery for Proximal LAD Diseaseolger Thiele, Patrick Neumann-Schniedewind, Stephan Jacobs, Enno Boudriot, Thomas Walther,
riedrich-Wilhelm Mohr, Gerhard Schuler, Volkmar Falk
hiele and colleagues conducted a randomized study to compare sirolimus-eluting stenting
SES) with minimally invasive direct coronary artery bypass (MIDCAB) surgery for patients
ith isolated proximal left anterior descending (LAD) stenosis. The primary end point was
oninferiority in freedom from major adverse cardiac events (MACE). MACE occurred in
.7% of patients in both groups, but there were differences in the individual components of
he combined end point. Death and myocardial infarction occurred in 1.5% versus 7.7% of
ES and MIDCAB patients, respectively, but target vessel revascularization occurred in 6.2%
f SES versus 0.0% of MIDCAB patients. In isolated proximal LAD disease, SES is
oninferior to MIDCAB surgery with a different side effect profile.(continued on page A-22)
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dLINICAL TRIALS2332Significant Benefits Seen From a Structured Exercise Program Post-CRTEditorial Commentshish Y. Patwala, Paul R. Woods, Lisa Sharp, David F. Goldspink, Lip B. Tan, David J. Wright
atwala and colleagues hypothesized that cardiac resynchronization therapy (CRT) might
mprove central cardiac output but not peripheral oxygen extraction. Patients who were 3
onths post-CRT were randomized to a thrice weekly structured exercise program or to
sual care. The exercise group showed further significant improvements in functional, exercise
emodynamic, and quality-of-life measures compared with the control group. These results
uggest that exercise training is useful for further augmenting the clinical benefits of CRT.EART FAILURE2343Percent Lowering of BNP Over the First 5 Days Predicts Subsequent MortalityEditorial Comment
Mihai Gheorghiade,lain Cohen-Solal, Damien Logeart, Bidan Huang, Danlin Cai, Markku S. Nieminen, Alexandre Mebazaa
ohen-Solal sought to determine if decreases in B-type natriuretic peptide (BNP) levels
uring the first few days of hospitalization predict subsequent mortality in patients with
cutely decompensated heart failure (ADHF) that require inotropes. The SURVIVE trial
andomized ADHF subjects to levosimendan or dobutamine. Responders, defined as those
atients who had a 30% decline in BNP levels from baseline, had lower all-cause mortality
ACM) at days 1, 3, and 5 than nonresponders. ACM through 31 days was 67% lower in
ay-5 BNP responders compared with nonresponders. Subjects whose BNP responds totreatment for ADHF have a lower risk of ACM than those with little or no BNP decrease.(continued on page A-23)
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HEART RHYTHM DISORDERS2353Clinical Variables Can Help to Distinguish Etiology of Narrow Complex SVTEditorial Commentsteban Gonza´lez-Torrecilla, Jesús Almendral, Angel Arenal, Felipe Atienza, Leonardo F. Atea,
ilvia del Castillo, Francisco Ferna´ndez-Avilés
ifferentiating atrioventricular nodal re-entrant tachycardias (AVNRTs) from orthodromic
eciprocating tachycardias (ORTs) using a concealed accessory pathway can be difficult.
onza´lez-Torrecilla and colleagues compared a blinded diagnostic interpretation of the
lectrocardiogram with basic clinical variables from a 7-item questionnaire. Age at the onset
f symptoms (odds ratio [OR]: 1.27), the presence of palpitations in the neck (OR: 3.54),
nd female sex (OR: 2.96) were more common for patients with AVNRTs. Neck palpitations
ere especially useful at predicting AVNRTs when the electrocardiogram was nondiagnostic.YPERTENSION
2363ystolic Gradient During Hyperemia Determines
Blood Pressure Response to Renal Artery Stenting CMEassoud A. Leesar, Jai Varma, Adam Shapira, Ibrahim Fahsah, Seyed T. Raza, Ziad Elghoul,
nthony C. Leonard, Karthikeyan Meganathan, Sohail Ikram
eesar and colleagues investigated the discordance between the high procedural success and
oderate clinical response rates in patients with renal artery stenosis (RAS) who undergo
tenting. Subjects with RAS were studied with renal translesional pressure gradients (TPGs)
sing a pressure wire, intravascular ultrasound, and angiographic parameters. The TPG was
btained both at rest and after induction of renal hyperemia with papaverine. A hyperemic
ystolic gradient (HSG) 21 mm Hg had the highest sensitivity, specificity, and predictive
ccuracy, each over 80%, for predicting an improvement in hypertension. An HSG 21 mm
g appears to indicate physiologically significant RAS that is affecting the blood pressure.(continued on page A-28)
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aARDIAC IMAGING2372MRI Technique Can Quantify Blood Flow in Skeletal Musclesen-Chau Wu, Emile Mohler III, Sarah J. Ratcliffe, Felix W. Wehrli, John A. Detre, Thomas F. Floyd
u and colleagues describe the novel application of continuous arterial spin-labeling (CASL)
agnetic resonance imaging (MRI) for measuring calf muscle perfusion in subjects with
arying degrees of peripheral arterial disease (PAD). Occlusive cuff pressure was applied to
reate 5 min of ischemia followed by a period of responsive hyperemic flow. Peak hyperemic
ow (PHF) and time-to-peak (TTP) were computed for the 4 muscle groups of the calf.
oth PHF and TTP correlated with PAD, as measured by the ankle-brachial index (ABI).
TP was abnormal with any degree of PAD; PHF was preserved for subjects with ABI
0.7. CASL flow measurements are useful for quantifying the effects of PAD on
icrovascular flow.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH
2378ustained Local Release of EPO
Stimulates Angiogenesis in an Ischemic Mouse ModelSaline
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later onghu Li, Hideshi Okada, Genzou Takemura, Masayasu Esaki, Hiroyuki Kobayashi, Hiromitsu Kanamori,
tta Kawamura, Rumi Maruyama, Takako Fujiwara, Hisayoshi Fujiwara, Yasuhiko Tabata,
hinya Minatoguchi
rythropoietin (EPO) is a potent angiogenic factor, but its use is limited by untoward
ystemic effects and its short half-life in the plasma. Li and colleagues developed injectable
rythropoietin-immersed gelatin hydrogel microspheres (EPO-GHM) that should slowly
elease EPO into the local tissue. These microspheres were injected into the hind limb
uscles of mice after ligation of the femoral artery; the results were compared to several
ontrol groups. After 8 weeks, the EPO-GHM group had significantly improved perfusion.
apillary and arteriolar density was significantly increased and there was no evidence of
ystemic effects such as increased hematocrit. This prolonged, localized drug delivery system
ppears to harness the beneficial effects of EPO on angiogenesis without systemic effects.
